UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net (loss) income	$ (51,095)	$ 57,527
(Loss) income from discontinued operations, net of income taxes	(12,866)	64,448
(Loss) from continuing operations, net of income taxes	(38,229)	(6,921)
Adjustments to reconcile loss from continuing operations, net of income taxes to net cash provided by (used in) operating activities:
Depreciation	8,298	6,115
Amortization of intangibles	4,801	2,844
Amortization of deferred financing costs	1,410	662
Change in deferred income tax	1,402	2,164
Compensation under stock-based compensation plans	7,260	4,398
Loss on extinguishment of debt	15,898	0
Equity in net loss of unconsolidated affiliate	661	0
Changes in assets and liabilities, net of amounts acquired in acquisitions:
Receivables, net of bad debt expense	(20,021)	88,227
Inventory	8,875	(17,873)
Prepaid expenses and other assets	838	4,822
Accounts payable	8,102	(34,425)
Claims payable	(5,275)	(1,099)
Amounts due to plan sponsors	(10,372)	(3,415)
Accrued interest	(3,832)	5,737
Accrued expenses and other liabilities	(5,212)	5,615
Net cash (used in) provided by operating activities from continuing operations	(25,396)	56,851
Net cash (used in) operating activities from discontinued operations	(12,866)	(31,599)
Net cash (used in) provided by operating activities	(38,262)	25,252
Cash flows from investing activities:
Purchases of property and equipment, net	(19,929)	(5,777)
Cash consideration paid for acquisitions, net of cash acquired	(285,039)	(41,746)
Net cash proceeds from sale of unconsolidated affiliate	8,509	0
Cash advances to unconsolidated affiliate	(2,348)	0
Cash consideration paid to DS Pharmacy	0	(2,935)
Cash consideration paid for unconsolidated affiliate, net of cash acquired	0	(7,827)
Net cash used in investing activities from continuing operations	(298,807)	(58,285)
Net cash provided by investing activities from discontinued operations	0	161,499
Net cash (used in) provided by investing activities	(298,807)	103,214
Cash flows from financing activities:
Proceeds from public stock offering	118,570	0
Proceeds from new senior credit facility, net of lender fees and other expenses	377,283	0
Repayment of 10 1/4% senior unsecured notes	(237,397)	0
Borrowings on line of credit	379,896	1,041,440
Repayments on line of credit	(364,859)	(1,105,262)
Repayments of capital leases	(809)	(3,210)
Net proceeds from exercise of common stock purchase warrants	399	0
Net proceeds from exercise of employee stock compensation plans	1,885	5,922
Surrender of stock to satisfy minimum tax withholding	0	(174)
Net cash provided by (used in) financing activities	274,968	(61,284)
Net change in cash and cash equivalents	(62,101)	67,182
Cash and cash equivalents - beginning of period	62,101	0
Cash and cash equivalents - end of period	0	67,182
DISCLOSURE OF CASH FLOW INFORMATION:
Cash paid during the period for interest	22,598	13,961
Cash paid during the period for income taxes	242	1,628
DISCLOSURE OF NON-CASH TRANSACTIONS:
Capital lease obligations incurred to acquire property and equipment	$ 0	$ 20